SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBridgepoint Regulatory News (BPT)

Share Price Information for Bridgepoint (BPT)

Share Price is delayed by 15 minutes
Get Live Data
244.40    5.60 (2.35%)
Bid:
244.60
Ask:
245.00
Spread: 0.40 (0.164%)
Market Cap: £2.14b
BPT Live PriceLast checked at - London Stock Exchange

Intraday Bridgepoint Share Chart

Share Buyback Programme

2 Jun 2025 07:00

RNS Number : 8488K
Bridgepoint Group plc
02 June 2025
 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER FOR SALE OF ANY SECURITIES OR AN OFFER OR INVITATION TO PURCHASE ANY SECURITIES IN ANY JURISDICTION OR A SOLICITATION OF ANY VOTE OR APPROVAL.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (DIRECTLY OR INDIRECTLY) IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

Bridgepoint Group plc("Bridgepoint" or the "Company")

Share Buyback Programme

 

2 June 2025

 

Bridgepoint today announces the reintroduction of a share buyback programme of up to £50 million (the "Buyback Programme"). The Buyback Programme will run from and including 2 June 2025 and is expected to be completed by 31 May 2026.

 

Bridgepoint's strategy and growth agenda, as outlined at the Capital Markets Day in October 2024, remains unchanged. However given ongoing market volatility there is a benefit in Bridgepoint reintroducing the flexibility to allocate some capital to repurchase its shares on an opportunistic basis.

 

Details of the Buyback Programme

 

Bridgepoint has appointed J.P. Morgan Securities plc ("JP Morgan Securities"), as riskless principal, in relation to the purchase of ordinary shares in Bridgepoint (the "Shares"). 

 

Such repurchases would take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volume. There is no certainty that any Share buybacks will be completed, or that the maximum amount of purchases under the Buyback Programme will occur. During any closed periods the Company and its Directors will not have any power to invoke any changes to the Buyback Programme.

 

These arrangements are in accordance with Bridgepoint's general authority to repurchase up to 82,393,098 Shares granted at its Annual General Meeting held on 15 May 2025 (the "2025 AGM"), Chapter 9 of the UK Listing Rules, and those provisions of Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and the Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). The number of Shares to be purchased under the Buyback Programme will not exceed 82,393,098 Shares and is therefore within the 2025 AGM approved limit.

 

Details of the authority granted at the 2025 AGM can be found on our website at https://www.bridgepointgroupplc.com/shareholder-centre/annual-general-meeting.

 

The sole purpose of these Share purchases is to reduce the Company's share capital. Any Shares purchased pursuant to the Buyback Programme will be cancelled. 

 

 

ENQUIRIES

 

Bridgepoint

 

Analysts and investors

Adam Key

adam.key@bridgepointgroup.com

+44 7833 748010

 

Media

Christian Jones / James Murray

christian.jones@bridgepointgroup.com james.murray@bridgepointgroup.com

+44 20 7034 3500

 

FGS Global (Public Relations Adviser to Bridgepoint)

 

James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911

Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233

bridgepoint-LON@fgsglobal.com   

 

Legal Entity Identifier (LEI): 213800KFNMVI8PDZX472

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCAMMTTMTAJBBA
Date   Source Headline
9th Jun 20267:00 amRNSHolding(s) in Company
12th May 20264:15 pmRNSResult of AGM
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 20264:00 pmRNSDirector/PDMR Shareholding
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 202610:00 amRNSAnnual Report and Accounts and Notice of AGM
23rd Mar 202610:45 amRNSIssue of Equity and Total Voting Rights
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
16th Mar 202611:30 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSFinal Results
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 202612:30 pmRNSIssue of Equity and Total Voting Rights
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202611:30 amRNSIssue of Equity
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.